Rolee Sharma
Kursi Road
Lucknow, UP 226026, India
Lucknow, UP 226026, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
In Vitro and In Silico Approaches for the Evaluation of Antimycobacterial and Biofilm Inhibition Activity of Asiatic Acid Against Dual Targets of Mycobacterium smegmatis.
Journal: Current topics in medicinal chemistry
Published: March 03, 2025
Identification of virulence genes and clade-specific markers through pan-genomic analysis of Leptospira.
Journal: BMC microbiology
Published: September 20, 2024
Treatment of Mycobacterium tuberculosis infected macrophages with Rifabutin loaded β-glucan microparticles induces macroautophagy mediated bacillary killing.
Journal: International journal of biological macromolecules
Published: August 12, 2024
"β-glucan signalling stimulates NOX-2 dependent autophagy and LC-3 associated autophagy (LAP) pathway".
Journal: International journal of biological macromolecules
Published: August 02, 2024
Correction: Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches.
Journal: Journal of neurovirology
Published: June 10, 2024
Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB.
Journal: Scientific reports
Published: March 22, 2024
Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches.
Journal: Journal of neurovirology
Published: March 11, 2024
Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in Mycobacterium tuberculosis from Plant-Derived Metabolites: An In Silico Study.
Journal: Antibiotics (Basel, Switzerland)
Published: June 25, 2022
Structure-based in silico and in vitro Analysis Reveals Asiatic Acid as Novel Potential Inhibitor of Mycobacterium tuberculosis Maltosyl Transferase.
Journal: Current computer-aided drug design
Published: February 21, 2022
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: October 05, 2020
Last Updated: 09/26/2026